SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying how well SB-715992 works in treating patients with
advanced or metastatic colorectal cancer. Drugs used in chemotherapy, such as SB-715992, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing.